Literature DB >> 2871398

Hepatitis B vaccines with pre-S gene product.

P Berthelot, R Neurath, A M Courouce, C Brechot, F Degos, F Tron, M Girard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2871398     DOI： 10.1016/s0140-6736(86)91860-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Pre-s mutation is a significant risk factor for hepatocellular carcinoma development: a long-term retrospective cohort study.

Authors:  Dong Hyun Sinn; Moon Seok Choi; Geum-Youn Gwak; Yong-Han Paik; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  Dig Dis Sci       Date:  2012-09-30       Impact factor: 3.199

2.  High prevalence of hepatitis B virus pre-s mutant in countries where it is endemic and its relationship with genotype and chronicity.

Authors:  Tran Thien-Tuan Huy; Hiroshi Ushijima; Khin Maung Win; Pairoj Luengrojanakul; Pradeep Krishna Shrestha; Zhao-Hua Zhong; Andrei V Smirnov; Teresa Casanovas Taltavull; Tetsutaro Sata; Kenji Abe
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

3.  Associations between pre-S deletion mutation of hepatitis B virus and risk of hepatocellular carcinoma in the Asian population: a meta-analysis.

Authors:  Chao Wang; Zhaowei Teng; Yun Zhu; Allan Z Zhao; Chunhua Sun
Journal:  Med Sci Monit       Date:  2015-04-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.